Founded

Address

Burrill & Co LLC
One Embarcadero Center
Suite 2700
San Francisco, CA 94111
United States

Open map


Recent investment activity

KANDO id: 2488

Corporate information

Founders
Registration country

Company type

Diversified global financial services firm focused on the life sciences industry

Funds managed

Fund Type Vintage Currency Committed capital
Burrill Life Sciences Capital Fund IV 2011 USD 500,000,000

Funding rounds

Investment preferences

Actual initial investment stage
N/A (1)
Venture (1)

Investment activity status
Not investing

Selected investments

Displaying 1 - 25 of 33
Profile Country Date Funding
Arete Therapeutics Inc A biotechnology company, engages in the discovery and development of drugs to treat diabetes, and inflammatory and cardiovascular diseases. Series A
Catalyst Biosciences Inc Developer of catalytic biopharmaceutical products based on engineered human proteases. Series C
Catalyst Biosciences Inc Developer of catalytic biopharmaceutical products based on engineered human proteases. Series B
Catalyst Biosciences Inc Developer of catalytic biopharmaceutical products based on engineered human proteases. Series A
Cellomics Inc N/A
Endocyte Inc Folate-based cancer and autoimmune disease therapies Series C
FerroKin Biosciences Inc A clinical stage biotechnology company dedicated to improving the management of patients with iron overload. N/A
Immunicon Corp Biotechnology company specializing in cell-based research and diagnostic products with an initial focus on cancer. N/A
Inhibitex Inc N/A
Intranasal Therapeutics Inc Specialty pharmaceutical company focused on developing nasally delivered pharmaceutical products. N/A
Light Sciences Oncology Inc Drug-device cancer therapy Series B
Logical Therapeutics Inc An early stage biotechnology company N/A
Neurotech Pharmaceuticals Inc (Neurotech Inc) Cell-based drugs for diseases of the eye. Series B
Nora Therapeutics Inc Specialty biopharmaceutical company that focuses on developing therapeutics to address clinical unmet needs in reproductive medicine. N/A
Osprey Pharmaceuticals USA Series A
Phytomedics Inc Biopharmaceutical company with a broad portfolio of novel compounds for chronic diseases. N/A
ProteoGenix Inc N/A
Scynexis Inc Provider of drug discovery, development, and manufacturing projects. N/A
Whiteglove House Call Health Inc N/A
Aclara Biosciences Inc Develops and distributes assay solutions for drug discovery and development N/A
Adlyfe Series A
Aerovance Inc N/A
Aerovance Inc Series C
AgraQuest Inc Discovery, development, manufacturing and marketing of biopesticides and low-chem pest and disease control, and yield enhancing products. N/A
Akermin Inc (A biocatalyst development company which develops and commercializes polymer technology.) N/A

Current team

Former team members

Employee Company Position
Dr John E Hamer Golden Pine Ventures LLC

Selected Products / Customers

Financials